We found that microinjection of DTT (1.0 mM, 1 μL per side) into the BLA reduced the level of SNO‐gephyrin (Figure S4A,B, Supporting Information), together with the improvement of anxiety‐like behaviors compared with that of vehicle group, which was demonstrated by their increased center time, center entries and center distance in the center zone of OFT, without changes in locomotor activity (Figure 3E,F). This evidence concerns the gene GPHN and Anxiety.